ArticleCell reports. Medicine2024

Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia.

Shady Adnan Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.